Cited by 159Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program

Open access
Allocco, Dominic J, Cannon, Louis A, Britt, Amy, Heil, John E, Nersesov, Andrey, Wehrenberg, Scott, Dawkins, Keith D, Kereiakes, Dean J·2010·Trials

Abstract

Background: Paclitaxel-eluting stents decrease angiographic and clinical restenosis following percutaneous coronary intervention compared to bare metal stents. TAXUS Element is a third-generation paclitaxel-eluting stent which incorporates a novel, thinner-strut, platinum-enriched metal alloy platform. The stent is intended to have enhanced radiopacity and improved deliverability compared to other paclitaxel-eluting stents. The safety and efficacy of the TAXUS Element stent are being evaluated in the pivotal PERSEUS clinical trials. Methods/Design: The PERSEUS trials include two parallel studies of the TAXUS Element stent in single, de novo coronary atherosclerotic lesions. The PERSEUS Workhorse study is a prospective, randomized (3:1), single-blind, non-inferiority trial in subjects with lesion length ≤28 mm and vessel diameter ≥2.75 mm to ≤4.0 mm which compares TAXUS Element to the TAXUS Express 2 paclitaxel-eluting stent system. The Workhorse study employs a novel Bayesian statistical approach that uses prior information to limit the number of study subjects exposed to the investigational device and thus provide a safer and more efficient analysis of the TAXUS Element stent. PERSEUS Small Vessel is a prospective, single-arm, superiority trial in subjects with lesion length ≤20 mm and vessel diameter ≥2.25 mm to <2.75 mm that compares TAXUS Element with a matched historical bare metal Express stent control. Discussion: The TAXUS PERSEUS clinical trial program uses a novel statistical approach to evaluate whether design and metal alloy iterations in the TAXUS Element stent platform provide comparable safety and improved procedural performance compared to the previous generation Express stent. PERSEUS trial enrollment is complete and primary endpoint data are expected in 2010. PERSEUS Workhorse and Small Vessel are registered at http://www.clinicaltrials.gov, identification numbers NCT00484315 and NCT00489541.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1745-6215-11-1

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Allocco, D. J., Cannon, L. A., Britt, A., Heil, J. E., Nersesov, A., Wehrenberg, S., Dawkins, K. D., & Kereiakes, D. J.
Affiliations
  • Boston Scientific (United States) (US)
  • Cardiac And Vascular Research Center Of Northern Michigan (US)
  • Christ Hospital (US)
Corresponding author
Kereiakes, Dean J
Venue
Trials
Published
2010-01-07
Volume
11
Issue
1
Pages
1-1
ISSN
1745-6215 (ISSN-L)
OpenAlex
W2139043704
Cited by
159
References
28
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2022: 8 · 2021: 34 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 19 · 2013: 7 · 2012: 8
FWCI
9.77
Type
journal article
Language
en
Open access
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • University of Connecticut
  • Boston Scientific Corporation
  • Cordis
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
paclitaxel-eluting stents, de novo coronary lesions, percutaneous coronary intervention, restenosis
MeSH terms
Australia, Bayes Theorem, Cardiovascular Agents, Chromium Alloys, Coronary Artery Disease, Data Interpretation, Statistical, Humans, New Zealand, Platelet Aggregation Inhibitors, Platinum, Prospective Studies, Prosthesis Design, Research Design, Severity of Illness Index, Singapore, Time Factors, United States, Stents, Angioplasty, Balloon, Coronary, Single-Blind Method, Treatment Outcome, Coronary Angiography, Paclitaxel, Drug-Eluting Stents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review